|
1
|
Park IK, Qian D, Kiel M, Becker MW,
Pihalja M, Weissman IL, Morrison SJ and Clarke MF: Bmi-1 is
required for maintenance of adult self-renewing haematopoietic stem
cells. Nature. 423:302–305. 2003.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Park IK, Morrison SJ and Clarke MF: Bmi1,
stem cells, and senescence regulation. J Clin Invest. 113:175–179.
2004.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY,
Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, et al: Bmi1 is
essential in Twist1-induced epithelial-mesenchymal transition. Nat
Cell Biol. 12:982–992. 2010.PubMed/NCBI View
Article : Google Scholar : Erratum in: Nat Cell
Biol 21, 533, 2019.
|
|
4
|
Adhikary S and Eilers M: Transcriptional
regulation and transformation by Myc proteins. Nat Rev Mol Cell
Biol. 6:635–645. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Kim J, Hwangbo J and Wong PK: p38
MAPK-Mediated Bmi-1 down-regulation and defective proliferation in
ATM-deficient neural stem cells can be restored by Akt activation.
PLoS One. 6(e16615)2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cao R, Tsukada Y and Zhang Y: Role of
Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol
Cell. 20:845–854. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bhattacharyya J, Mihara K, Ohtsubo M,
Yasunaga S, Takei Y, Yanagihara K, Sakai A, Hoshi M, Takihara Y and
Kimura A: Overexpression of BMI-1 correlates with drug resistance
in B-cell lymphoma cells through the stabilization of survivin
expression. Cancer Sci. 103:34–41. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cao L, Bombard J, Cintron K, Sheedy J,
Weetall ML and Davis TW: BMI1 as a novel target for drug discovery
in cancer. J Cell Biochem. 112:2729–2741. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Venkatesh S and Workman JL: Histone
exchange, chromatin structure and the regulation of transcription.
Nat Rev Mol Cell Biol. 16:178–189. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Siddique HR, Parray A, Tarapore RS, Wang
L, Mukhtar H, Karnes RJ, Deng Y, Konety BR and Saleem M: BMI1
polycomb group protein acts as a master switch for growth and death
of tumor cells: Regulates TCF4-transcriptional factor-induced BCL2
signaling. PLoS One. 8(e60664)2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Alkema MJ, Wiegant J, Raap AK, Berns A and
van Lohuizen M: Characterization and chromosomal localization of
the human proto-oncogene BMI-1. Hum Mol Genet. 2:1597–1603.
1993.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Freemont PS, Hanson IM and Trowsdale J: A
novel cysteine-rich sequence motif. Cell. 64:483–484.
1991.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dimri GP, Martinez JL, Jacobs JJL,
Keblusek P, Itahana K, Van Lohuizen M, Campisi J, Wazer DE and Band
V: The Bmi-1 oncogene induces telomerase activity and
immortalizes human mammary epithelial cells. Cancer Res.
62:4736–4745. 2002.PubMed/NCBI
|
|
14
|
Cohen KJ, Hanna JS, Prescott JE and Dang
CV: Transformation by the Bmi-1 oncoprotein correlates with its
subnuclear localization but not its transcriptional suppression
activity. Mol Cell Biol. 16:5527–5535. 1996.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Buchwald G, van der Stoop P, Weichenrieder
O, Perrakis A, van Lohuizen M and Sixma TK: Structure and E3-ligase
activity of the Ring-Ring complex of polycomb proteins Bmi1 and
Ring1b. EMBO J. 25:2465–2474. 2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rogers S, Wells R and Rechsteiner M: Amino
acid sequences common to rapidly degraded proteins: The PEST
hypothesis. Science. 234:364–368. 1986.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hoffman B and Liebermann DA: Apoptotic
signaling by c-MYC. Oncogene. 27:6462–6472. 2008.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Jacobs JJL, Scheijen B, Voncken JW,
Kieboom K, Berns A and van Lohuizen M: Bmi-1 collaborates with
c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via
INK4a/ARF. Genes Dev. 13:2678–2690. 1999.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cenci T, Martini M, Montano N,
D'Alessandris QG, Falchetti ML, Annibali D, Savino M, Bianchi F,
Pierconti F, Nasi S, et al: Prognostic relevance of c-Myc and BMI1
expression in patients with glioblastoma. Am J Clin Pathol.
138:390–396. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Guo WJ, Datta S, Band V and Dimri GP:
Mel-18, a polycomb group protein, regulates cell proliferation and
senescence via transcriptional repression of Bmi-1 and c-Myc
oncoproteins. Mol Biol Cell. 18:536–546. 2007.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Weiss WA, Aldape K, Mohapatra G,
Feuerstein BG and Bishop JM: Targeted expression of MYCN causes
medulloblastoma in transgenic mice. EMBO J. 16:2985–2995.
1997.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ochiai H, Takenobu H, Nakagawa A,
Yamaguchi Y, Kimura M, Ohira M, Okimoto Y, Fujimura Y, Koseki H,
Kohno Y, et al: Bmi1 is a MYCN target gene that regulates
tumorigenesis through repression of KIF1Bβ and TSLC1
in neuroblastoma. Oncogene. 29:2681–2690. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Huang R, Cheung NKV, Vider J, Cheung IY,
Gerald WL, Tickoo SK, Holland EC and Blasberg RG: MYCN and MYC
regulate tumor proliferation and tumorigenesis directly through
BMI1 in human neuroblastomas. FASEB J. 25:4138–4149.
2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ishida A, Asano H, Hasegawa M, Koseki H,
Ono T, Yoshida MC, Taniguchi M and Kanno M: Cloning and chromosome
mapping of the human Mel-18 gene which encodes a DNA-binding
protein with a new ‘RING-finger’ motif. Gene. 129:249–255.
1993.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tetsu O, Ishihara H, Kanno R, Kamiyasu M,
Inoue H, Tokuhisa T, Taniguchi M and Kanno M: mel-18 negatively
regulates cell cycle progression upon B cell antigen receptor
stimulation through a cascade leading to c-myc/cdc25. Immunity.
9:439–448. 1998.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Guo WJ, Zeng MS, Yadav A, Song LB, Guo BH,
Band V and Dimri GP: Mel-18 acts as a tumor suppressor by
repressing Bmi-1 expression and down-regulating Akt activity in
breast cancer cells. Cancer Res. 67:5083–5089. 2007.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Liu-Bryan R and Terkeltaub R: Chondrocyte
innate immune myeloid differentiation factor 88-dependent signaling
drives procatabolic effects of the endogenous Toll-like receptor
2/Toll-like receptor 4 ligands low molecular weight hyaluronan and
high mobility group box chromosomal protein 1 in mice. Arthritis
Rheum. 62:2004–2012. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li SKM, Smith DK, Leung WY, Cheung AM, Lam
EW, Dimri GP and Yao KM: FoxM1c counteracts oxidative
stress-induced senescence and stimulates Bmi-1 expression. J Biol
Chem. 283:16545–16553. 2008.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cheasley D, Pereira L, Lightowler S,
Vincan E, Malaterre J and Ramsay RG: Myb controls intestinal stem
cell genes and self-renewal. Stem Cells. 29:2042–2050.
2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vargova K, Curik N, Burda P, Basova P,
Kulvait V, Pospisil V, Savvulidi F, Kokavec J, Necas E, Berkova A,
et al: MYB transcriptionally regulates the miR-155 host gene in
chronic lymphocytic leukemia. Blood. 117:3816–3825. 2011.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Waldron T, De Dominici M, Soliera AR,
Audia A, Iacobucci I, Lonetti A, Martinelli G, Zhang Y, Martinez R,
Hyslop T, et al: c-Myb and its target Bmi1 are required for
p190BCR/ABL leukemogenesis in mouse and human cells. Leukemia.
26:644–653. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Martin A and Cano A: Tumorigenesis: Twist1
links EMT to self-renewal. Nat Cell Biol. 12:924–925.
2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yang MH, Hsu DSS, Wang HW, Wang HJ, Lan
HY, Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, et al: Bmi1 is
essential in Twist1-induced epithelial-mesenchymal transition. Nat
Cell Biol. 12:982–992. 2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wu KJ: Direct activation of Bmi1 by
Twist1: Implications in cancer stemness, epithelial-mesenchymal
transition, and clinical significance. Chang Gung Med J.
34:229–238. 2011.PubMed/NCBI
|
|
35
|
Wu CY, Hung JJ and Wu KJ: Linkage between
Twist1 and Bmi1: Molecular mechanism of cancer metastasis/stemness
and clinical implications. Clin Exp Pharmacol Physiol. 39:668–673.
2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yang J, Chai L, Liu F, Fink LM, Lin P,
Silberstein LE, Amin HM, Ward DC and Ma Y: Bmi-1 is a target
gene for SALL4 in hematopoietic and leukemic cells. Proc Natl Acad
Sci USA. 104:10494–10499. 2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Vander Griend DJ, D'Antonio J, Gurel B,
Antony L, Demarzo AM and Isaacs JT: Cell-autonomous intracellular
androgen receptor signaling drives the growth of human prostate
cancer initiating cells. Prostate. 70:90–99. 2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Irwin M, Marin MC, Phillips AC, Seelan RS,
Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH, et al:
Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature.
407:645–648. 2000.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Nowak K, Kerl K, Fehr D, Kramps C, Gessner
C, Killmer K, Samans B, Berwanger B, Christiansen H and Lutz W:
BMI1 is a target gene of E2F-1 and is strongly expressed in
primary neuroblastomas. Nucleic Acids Res. 34:1745–1754.
2006.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ammirante M, Kuraishy AI, Shalapour S,
Strasner A, Ramirez-Sanchez C, Zhang W, Shabaik A and Karin M: An
IKKα-E2F1-BMI1 cascade activated by infiltrating B cells controls
prostate regeneration and tumor recurrence. Genes Dev.
27:1435–1440. 2013.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Gupta S, Takebe N and Lorusso P: Targeting
the Hedgehog pathway in cancer. Ther Adv Med Oncol. 2:237–250.
2010.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Briscoe J and Thérond PP: The mechanisms
of Hedgehog signalling and its roles in development and disease.
Nat Rev Mol Cell Biol. 14:416–429. 2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Liu S, Dontu G, Mantle ID, Patel S, Ahn
NS, Jackson KW, Suri P and Wicha MS: Hedgehog signaling and Bmi-1
regulate self-renewal of normal and malignant human mammary stem
cells. Cancer Res. 66:6063–6071. 2006.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Wang X, Venugopal C, Manoranjan B,
McFarlane N, O'Farrell E, Nolte S, Gunnarsson T, Hollenberg R,
Kwiecien J, Northcott P, et al: Sonic hedgehog regulates Bmi1 in
human medulloblastoma brain tumor-initiating cells. Oncogene.
31:187–199. 2012.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wang H, Liu H, Li X, Zhao J, Zhang H, Mao
J, Zou Y, Zhang H, Zhang S, Hou W, et al: Estrogen receptor
α-coupled Bmi1 regulation pathway in breast cancer and its clinical
implications. BMC Cancer. 14(122)2014.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Wang HB, Liu GH, Zhang H, Xing S, Hu LJ,
Zhao WF, Xie B, Li MZ, Zeng BH, Li Y, et al: Sp1 and c-Myc regulate
transcription of BMI1 in nasopharyngeal carcinoma. FEBS J.
280:2929–2944. 2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Yu T, Chen X, Zhang W, Colon D, Shi J,
Napier D, Rychahou P, Lu W, Lee EY, Weiss HL, et al: Regulation of
the potential marker for intestinal cells, Bmi1, by β-catenin and
the zinc finger protein KLF4: Implications for colon cancer. J Biol
Chem. 287:3760–3768. 2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Jia Y, Chen J, Zhu H, Jia ZH and Cui MH:
Aberrantly elevated redox sensing factor Nrf2 promotes cancer stem
cell survival via enhanced transcriptional regulation of ABCG2 and
Bcl-2/Bmi-1 genes. Oncol Rep. 34:2296–2304. 2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Qian T, Lee JY, Park JH, Kim HJ and Kong
G: Id1 enhances RING1b E3 ubiquitin ligase activity through the
Mel-18/Bmi-1 polycomb group complex. Oncogene. 29:5818–5827.
2010.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Bommi PV, Dimri M, Sahasrabuddhe AA,
Khandekar J and Dimri GP: The polycomb group protein BMI1 is a
transcriptional target of HDAC inhibitors. Cell Cycle. 9:2663–2673.
2010.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Slaby O, Svoboda M, Michalek J and Vyzula
R: MicroRNAs in colorectal cancer: Translation of molecular biology
into clinical application. Mol Cancer. 8(102)2009.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Bhattacharyya J, Mihara K, Yasunaga S,
Tanaka H, Hoshi M, Takihara Y and Kimura A: BMI-1 expression is
enhanced through transcriptional and posttranscriptional regulation
during the progression of chronic myeloid leukemia. Ann Hematol.
88:333–340. 2009.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Godlewski J, Nowicki MO, Bronisz A,
Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca
EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal
factor by microRNA-128 inhibits glioma proliferation and
self-renewal. Cancer Res. 68:9125–9130. 2008.PubMed/NCBI View Article : Google Scholar
|
|
55
|
He X, Dong Y, Wu CW, Zhao Z, Ng SS, Chan
FK, Sung JJ and Yu J: MicroRNA-218 inhibits cell cycle progression
and promotes apoptosis in colon cancer by downregulating BMI1
polycomb ring finger oncogene. Mol Med. 18:1491–1498.
2013.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Dang Z, Xu WH, Lu P, Wu N, Liu J, Ruan B,
Zhou L, Song WJ and Dou KF: MicroRNA-135a inhibits cell
proliferation by targeting Bmi1 in pancreatic ductal
adenocarcinoma. Int J Biol Sci. 10:733–745. 2014.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Xu L, Li Y, Yan D, He J and Liu D:
MicroRNA-183 inhibits gastric cancer proliferation and invasion via
directly targeting Bmi-1. Oncol Lett. 8:2345–2351. 2014.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Wu C, Zheng X, Li X, Fesler A, Hu W, Chen
L, Xu B, Wang Q, Tong A, Burke S, et al: Reduction of gastric
cancer proliferation and invasion by miR-15a mediated suppression
of Bmi-1 translation. Oncotarget. 7:14522–14536. 2016.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Dong P, Kaneuchi M, Watari H, Hamada J,
Sudo S, Ju J and Sakuragi N: MicroRNA-194 inhibits epithelial to
mesenchymal transition of endometrial cancer cells by targeting
oncogene BMI-1. Mol Cancer. 10(99)2011.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Dimri M, Carroll JD, Cho JH and Dimri GP:
microRNA-141 regulates BMI1 expression and induces senescence in
human diploid fibroblasts. Cell Cycle. 12:3537–3546.
2013.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Sugihara H, Ishimoto T, Watanabe M,
Sawayama H, Iwatsuki M, Baba Y, Komohara Y, Takeya M and Baba H:
Identification of miR-30e* regulation of Bmi1 expression
mediated by tumor-associated macrophages in gastrointestinal
cancer. PLoS One. 8(e81839)2013.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Yu J, Lu Y, Cui D, Li E, Zhu Y, Zhao Y,
Zhao F and Xia S: miR-200b suppresses cell proliferation, migration
and enhances chemosensitivity in prostate cancer by regulating
Bmi-1. Oncol Rep. 31:910–918. 2014.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Zhang Y, Zhou SY, Yan HZ, Xu DD, Chen HX,
Wang XY, Wang X, Liu YT, Zhang L, Wang S, et al: miR-203 inhibits
proliferation and self-renewal of leukemia stem cells by targeting
survivin and Bmi-1. Sci Rep. 6(19995)2016.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Qi X, Li J, Zhou C, Lv C and Tian M:
MicroRNA-320a inhibits cell proliferation, migration and invasion
by targeting BMI-1 in nasopharyngeal carcinoma. FEBS Lett.
588:3732–3738. 2014.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Liu S, Tetzlaff MT, Cui R and Xu X:
miR-200c inhibits melanoma progression and drug resistance through
down-regulation of BMI-1. Am J Pathol. 181:1823–1835.
2012.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Bhattacharya R, Nicoloso M, Arvizo R, Wang
E, Cortez A, Rossi S, Calin GA and Mukherjee P: miR-15a and miR-16
control Bmi-1 expression in ovarian cancer. Cancer Res.
69:9090–9095. 2009.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Venkataraman S, Alimova I, Fan R, Harris
P, Foreman N and Vibhakar R: MicroRNA 128a increases intracellular
ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer
cell growth by promoting senescence. PLoS One.
5(e10748)2010.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Nanta R, Kumar D, Meeker D, Rodova M, Van
Veldhuizen PJ, Shankar S and Srivastava RK: NVP-LDE-225
(Erismodegib) inhibits epithelial-mesenchymal transition and human
prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by
regulating Bmi-1 and microRNA-128. Oncogenesis.
2(e42)2013.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Kreso A, van Galen P, Pedley NM,
Lima-Fernandes E, Frelin C, Davis T, Cao L, Baiazitov R, Du W,
Sydorenko N, et al: Self-renewal as a therapeutic target in human
colorectal cancer. Nat Med. 20:29–36. 2014.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Li Y, Hu J, Guan F, Song L, Fan R, Zhu H,
Hu X, Shen E and Yang B: Copper induces cellular senescence in
human glioblastoma multiforme cells through downregulation of
Bmi-1. Oncol Rep. 29:1805–1810. 2013.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Xuan HQ, Xue W, Pan JH, Sha JJ, Dong BJ
and Huang YR: Downregulation of miR-221,-30d, and-15a contributes
to pathogenesis of prostate cancer by targeting Bmi-1. Biochemistry
(Mosc). 80:276–283. 2015.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Guo JL, Li WP, Shi HL, Xie XH, Li LS, Tang
HL, Wu MQ, Kong Y, Yang L, Gao J, et al: Synergistic effects of
curcumin with emodin against the proliferation and invasion of
breast cancer cells through upregulation of miR-34a. Mol Cell
Biochem. 382:103–111. 2013.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Lin SL, Chang DC, Ying SY, Leu D and Wu
DTS: MicroRNA miR-302 inhibits the tumorigenecity of human
pluripotent stem cells by coordinate suppression of the CDK2 and
CDK4/6 cell cycle pathways. Cancer Res. 70:9473–9482.
2010.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Li TT, Jian XY, He H, Lai QH, Li XZ, Deng
DL, Liu TF, Zhu JH, Jiao HL, Ye YP, et al: MiR-452 promotes an
aggressive colorectal cancer phenotype by regulating a
Wnt/β-catenin positive feedback loop. J Exp Clin Cancer Res.
37(238)2018.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Liu LP, Chen K, Wu JH, Shi L, Hu B, Cheng
SY, Li MF and Song LB: Downregulation of miR-452 promotes stem-like
traits and tumorigenicity of gliomas. Clin Cancer Res.
19:3429–3438. 2013.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Li X, Song Y, Liu D, Zhao J, Xu J, Ren J,
Hu Y, Wang Z, Hou Y and Zhao G: MiR-495 promotes senescence of
mesenchymal stem cells by targeting Bmi-1. Cell Physiol Biochem.
42:780–796. 2017.PubMed/NCBI View Article : Google Scholar
|
